Yongfei Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yongfei Hu has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Dong Wang
Department of General Practice, General Practice Center, The Seventh Affiliated Hospital Southern Medical University Foshan China
5 shared publications - Zhili Rong
Cancer Research Institute, School of Basic Medical Sciences, State Key Laboratory of Multi-organ Injury Prevention and Treatment, Guangdong Province Key Laboratory of Immune Regulation and Immunotherapy, Southern Medical University, Guangzhou, China
4 shared publications - Bing Liu
State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Senior Department of Hematology, Fifth Medical Center, Medical Innovation Research Department, Chinese PLA General Hospital, Beijing, China
2 shared publications - Hongxin Huang
Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China
2 shared publications - Jiajian Zhou
Dermatology Hospital Southern Medical University Guangzhou China
2 shared publications - Ying Lin
Cancer Research Institute, School of Basic Medical Sciences, State Key Laboratory of Multi-organ Injury Prevention and Treatment, Guangdong Province Key Laboratory of Immune Regulation and Immunotherapy, Southern Medical University, Guangzhou, China
2 shared publications
Latest Publications
- 24 August 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 195 (5) , 881-882
Methodological discussion regarding the independent evaluation of a CE-marked AI smartphone application for skin cancer screening
This comment letter highlights methodological and analytical considerations in the evaluation of a CE-marked AI smartphone application for skin cancer screening, including failed image-capture cases, paired diagnostic comparisons, skin phototype-stratified performance and assessment of clinical utility.
- 24 August 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 195 (5) , 881-882
Methodological discussion regarding the independent evaluation of a CE-marked AI smartphone application for skin cancer screening
This comment letter highlights methodological and analytical considerations in the evaluation of a CE-marked AI smartphone application for skin cancer screening, including failed image-capture cases, paired diagnostic comparisons, skin phototype-stratified performance and assessment of clinical utility.
- Open Access
- 4 March 2025
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 23 (2)
Biological Data Resources and Machine Learning Frameworks for Hematology Research
Hematology research has greatly benefited from the integration of diverse biological data resources and advanced machine learning (ML) frameworks. This integration has not only deepened our understanding of blood diseases such as leukemia and lymphoma, but also enhanced diagnostic accuracy and personalized treatment strategies. By applying ML algorithms to analyze large-scale biological data, researchers can more effectively identify disease patterns, predict treatment responses, and provide new perspectives for the diagnosis and treatment of hematologic disorders. Here, we provide an overview of the current landscape of biological data resources and the application of ML frameworks pertinent to hematology research.
- 4 March 2025
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 23 (2)
Open AccessBiological Data Resources and Machine Learning Frameworks for Hematology Research
Hematology research has greatly benefited from the integration of diverse biological data resources and advanced machine learning (ML) frameworks. This integration has not only deepened our understanding of blood diseases such as leukemia and lymphoma, but also enhanced diagnostic accuracy and personalized treatment strategies. By applying ML algorithms to analyze large-scale biological data, researchers can more effectively identify disease patterns, predict treatment responses, and provide new perspectives for the diagnosis and treatment of hematologic disorders. Here, we provide an overview of the current landscape of biological data resources and the application of ML frameworks pertinent to hematology research.
- 29 August 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (3) , 508-513.e2
TFAM Deficiency‒Mediated Mitochondrial Disorder Affects Langerhans Cell Maintenance and Function
- 29 August 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (3) , 508-513.e2
TFAM Deficiency‒Mediated Mitochondrial Disorder Affects Langerhans Cell Maintenance and Function
- Open Access
- 25 April 2022
- Published by Springer Nature in BMC Biology
- Vol. 20 (1) , 1-16
Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity
Background: The CRISPR-Cas12a (formerly Cpf1) system is a versatile gene-editing tool with properties distinct from the broadly used Cas9 system. Features such as recognition of T-rich protospacer-adjacent motif (PAM) and generation of sticky breaks, as well as amenability for multiplex editing in a single crRNA and lower off-target nuclease activity, broaden the targeting scope of available tools and enable more accurate genome editing. However, the widespread use of the nuclease for gene editing, especially in clinical applications, is hindered by insufficient activity and specificity despite previous efforts to improve the system. Currently reported Cas12a variants achieve high activity with a compromise of specificity. Here, we used structure-guided protein engineering to improve both editing efficiency and targeting accuracy of Acidaminococcus sp. Cas12a (AsCas12a) and Lachnospiraceae bacterium Cas12a (LbCas12a). Results: We created new AsCas12a variant termed “AsCas12a-Plus” with increased activity (1.5~2.0-fold improvement) and specificity (reducing off-targets from 29 to 23 and specificity index increased from 92% to 94% with 33 sgRNAs), and this property was retained in multiplex editing and transcriptional activation. When used to disrupt the oncogenic BRAFV600E mutant, AsCas12a-Plus showed less off-target activity while maintaining comparable editing efficiency and BRAFV600E cancer cell killing. By introducing the corresponding substitutions into LbCas12a, we also generated LbCas12a-Plus (activity improved ~1.1-fold and off-targets decreased from 20 to 12 while specificity index increased from 78% to 89% with 15 sgRNAs), suggesting this strategy may be generally applicable across Cas12a orthologs. We compared Cas12a-Plus, other variants described in this study, and the reported enCas12a-HF, enCas12a, and Cas12a-ultra, and found that Cas12a-Plus outperformed other variants with a good balance for enhanced activity and improved specificity. Conclusions: Our discoveries provide alternative AsCas12a and LbCas12a variants with high specificity and activity, which expand the gene-editing toolbox and can be more suitable for clinical applications.
- 25 April 2022
- Published by Springer Nature in BMC Biology
- Vol. 20 (1) , 1-16
Open AccessEngineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity
Background: The CRISPR-Cas12a (formerly Cpf1) system is a versatile gene-editing tool with properties distinct from the broadly used Cas9 system. Features such as recognition of T-rich protospacer-adjacent motif (PAM) and generation of sticky breaks, as well as amenability for multiplex editing in a single crRNA and lower off-target nuclease activity, broaden the targeting scope of available tools and enable more accurate genome editing. However, the widespread use of the nuclease for gene editing, especially in clinical applications, is hindered by insufficient activity and specificity despite previous efforts to improve the system. Currently reported Cas12a variants achieve high activity with a compromise of specificity. Here, we used structure-guided protein engineering to improve both editing efficiency and targeting accuracy of Acidaminococcus sp. Cas12a (AsCas12a) and Lachnospiraceae bacterium Cas12a (LbCas12a). Results: We created new AsCas12a variant termed “AsCas12a-Plus” with increased activity (1.5~2.0-fold improvement) and specificity (reducing off-targets from 29 to 23 and specificity index increased from 92% to 94% with 33 sgRNAs), and this property was retained in multiplex editing and transcriptional activation. When used to disrupt the oncogenic BRAFV600E mutant, AsCas12a-Plus showed less off-target activity while maintaining comparable editing efficiency and BRAFV600E cancer cell killing. By introducing the corresponding substitutions into LbCas12a, we also generated LbCas12a-Plus (activity improved ~1.1-fold and off-targets decreased from 20 to 12 while specificity index increased from 78% to 89% with 15 sgRNAs), suggesting this strategy may be generally applicable across Cas12a orthologs. We compared Cas12a-Plus, other variants described in this study, and the reported enCas12a-HF, enCas12a, and Cas12a-ultra, and found that Cas12a-Plus outperformed other variants with a good balance for enhanced activity and improved specificity. Conclusions: Our discoveries provide alternative AsCas12a and LbCas12a variants with high specificity and activity, which expand the gene-editing toolbox and can be more suitable for clinical applications.
- Open Access
- 7 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (1) , eabg5369
Single-cell architecture and functional requirement of alternative splicing during hematopoietic stem cell formation
AS program is essential for HSC formation.
- 7 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (1) , eabg5369
Open AccessSingle-cell architecture and functional requirement of alternative splicing during hematopoietic stem cell formation
AS program is essential for HSC formation.
- Open Access
- 1 August 2021
- Published by Elsevier in Cell Reports
- Vol. 36 (6) , 109524
Single-cell transcriptome analysis reveals the dynamics of human immune cells during early fetal skin development
- 1 August 2021
- Published by Elsevier in Cell Reports
- Vol. 36 (6) , 109524
Open AccessSingle-cell transcriptome analysis reveals the dynamics of human immune cells during early fetal skin development
- Open Access
- 2 July 2021
- Published by Springer Nature in Communications Biology
- Vol. 4 (1) , 1-8
Tag-seq: a convenient and scalable method for genome-wide specificity assessment of CRISPR/Cas nucleases
Genome-wide identification of DNA double-strand breaks (DSBs) induced by CRISPR-associated protein (Cas) systems is vital for profiling the off-target events of Cas nucleases. However, current methods for off-target discovery are tedious and costly, restricting their widespread applications. Here we present an easy alternative method for CRISPR off-target detection by tracing the integrated oligonucleotide Tag using next-generation-sequencing (CRISPR-Tag-seq, or Tag-seq). Tag-seq enables rapid and convenient profiling of nuclease-induced DSBs by incorporating the optimized double-stranded oligodeoxynucleotide sequence (termed Tag), adapters, and PCR primers. Moreover, we employ a one-step procedure for library preparation in Tag-seq, which can be applied in the routine workflow of a molecular biology laboratory. We further show that Tag-seq successfully determines the cleavage specificity of SpCas9 variants and Cas12a/Cpf1 in a large-scale manner, and discover the integration sites of exogenous genes introduced by the Sleeping Beauty transposon. Our results demonstrate that Tag-seq is an efficient and scalable approach to genome-wide identification of Cas-nuclease-induced off-targets.
- 2 July 2021
- Published by Springer Nature in Communications Biology
- Vol. 4 (1) , 1-8
Open AccessTag-seq: a convenient and scalable method for genome-wide specificity assessment of CRISPR/Cas nucleases
Genome-wide identification of DNA double-strand breaks (DSBs) induced by CRISPR-associated protein (Cas) systems is vital for profiling the off-target events of Cas nucleases. However, current methods for off-target discovery are tedious and costly, restricting their widespread applications. Here we present an easy alternative method for CRISPR off-target detection by tracing the integrated oligonucleotide Tag using next-generation-sequencing (CRISPR-Tag-seq, or Tag-seq). Tag-seq enables rapid and convenient profiling of nuclease-induced DSBs by incorporating the optimized double-stranded oligodeoxynucleotide sequence (termed Tag), adapters, and PCR primers. Moreover, we employ a one-step procedure for library preparation in Tag-seq, which can be applied in the routine workflow of a molecular biology laboratory. We further show that Tag-seq successfully determines the cleavage specificity of SpCas9 variants and Cas12a/Cpf1 in a large-scale manner, and discover the integration sites of exogenous genes introduced by the Sleeping Beauty transposon. Our results demonstrate that Tag-seq is an efficient and scalable approach to genome-wide identification of Cas-nuclease-induced off-targets.
- Top Cited PapersOpen Access
- 17 June 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-16
Single-cell RNA-seq reveals fibroblast heterogeneity and increased mesenchymal fibroblasts in human fibrotic skin diseases
Fibrotic skin disease represents a major global healthcare burden, characterized by fibroblast hyperproliferation and excessive accumulation of extracellular matrix. Fibroblasts are found to be heterogeneous in multiple fibrotic diseases, but fibroblast heterogeneity in fibrotic skin diseases is not well characterized. In this study, we explore fibroblast heterogeneity in keloid, a paradigm of fibrotic skin diseases, by using single-cell RNA-seq. Our results indicate that keloid fibroblasts can be divided into 4 subpopulations: secretory-papillary, secretory-reticular, mesenchymal and pro-inflammatory. Interestingly, the percentage of mesenchymal fibroblast subpopulation is significantly increased in keloid compared to normal scar. Functional studies indicate that mesenchymal fibroblasts are crucial for collagen overexpression in keloid. Increased mesenchymal fibroblast subpopulation is also found in another fibrotic skin disease, scleroderma, suggesting this is a broad mechanism for skin fibrosis. These findings will help us better understand skin fibrotic pathogenesis, and provide potential targets for fibrotic disease therapies.
- 17 June 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-16
Top Cited PapersOpen AccessSingle-cell RNA-seq reveals fibroblast heterogeneity and increased mesenchymal fibroblasts in human fibrotic skin diseases
Fibrotic skin disease represents a major global healthcare burden, characterized by fibroblast hyperproliferation and excessive accumulation of extracellular matrix. Fibroblasts are found to be heterogeneous in multiple fibrotic diseases, but fibroblast heterogeneity in fibrotic skin diseases is not well characterized. In this study, we explore fibroblast heterogeneity in keloid, a paradigm of fibrotic skin diseases, by using single-cell RNA-seq. Our results indicate that keloid fibroblasts can be divided into 4 subpopulations: secretory-papillary, secretory-reticular, mesenchymal and pro-inflammatory. Interestingly, the percentage of mesenchymal fibroblast subpopulation is significantly increased in keloid compared to normal scar. Functional studies indicate that mesenchymal fibroblasts are crucial for collagen overexpression in keloid. Increased mesenchymal fibroblast subpopulation is also found in another fibrotic skin disease, scleroderma, suggesting this is a broad mechanism for skin fibrosis. These findings will help us better understand skin fibrotic pathogenesis, and provide potential targets for fibrotic disease therapies.